<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <link rel="stylesheet" href="exercise-1-style.css">
    <title>Exercice 1</title>
</head>
<body>
    <div class="main-container">
        <!-- top section -->
        <div class="top">
            <h1><strong>Treating patients: A Challenge, or Not?</strong></h1>
        <p>Sponsored by Somemed Inc.</p>
        <h2 class="title-color-bg">Significant challenges exist when managing PHN in the elderly <sup>1</sup></h2>
            <p class="margin-bottom"><strong class="text-line-style">Treatment considerations</strong><sup>1</sup></p>
    
            <ul class="margin-top">
                <li>The patient is typically a human</li>
                <li>Elderly patients frequently have multiple comorbidities, take multiple medications, and are particularly sensitive to drug side
                    effects</li>
                <li>In elderly patients with impaired physical function, drugs that cause dizziness, drowsiness, or somnolence may increase the
                    risk of falls</li>
            </ul>
        <h2 class="title-color-bg">LOREM<sup>&reg;</sup> (loremin) can help with the challenge of brain management in the humans<sup>2</sup></h2>

        <p class="margin-bottom"><strong>Indication and Usage</strong></p>
        <p class="margin-top">LOREM<sup>&reg;</sup>(loremin) tablets are indicated for the management of human brain activities. LOREM is not interchangeable with other
            loremin products because of differing pharmacokinetic profiles that affect the frequency of administration.</p>
            <p>For more information about LOREM, please see the full <a href="http://www.nytimes.com/2014/11/18/science/monarchs-may-be-lovedto-death.html?ref=science">Prescribing Information</a> and <a href="http://artsbeat.blogs.nytimes.com/2014/11/23/homeland-recap-wassaul-heroic-or-somethingelse/?ref=arts">Medication Guide</a>.</p>
        </div>
        <!-- middle section  -->
        <div class="img">
            <img src="Exercise1-code-challenge-image.png" alt="cat sitting">
        </div>
        <!-- bottom section -->
        <div class="bottom">
            <p><strong>References:</strong></p>
                <ul>
                    <li>1. Gupta A, Li S. Safety and efficacy of once-daily gastroretentive loreminar in patients with postherpetic neuralgia aged 75 years and over. Drugs Aging.
                        2013;30:999-1008.
                        </li>
                    <li>2. Harden RN, Kaye AD, Kintanar T, Argoff CE. Evidence-based guidance for the management of postherpetic neuralgia in primary care. Postgrad Med.
                        2013;125:191-202.</li>
                </ul>
                <p class="reg-copy">&copy; November 2017, Somemed Inc. All rights reserved. HAH-0001</p>
        </div>
    </div>
</body>
</html>